Live with Dr. Jane Ruby: Trump's 2019 executive order enabled rushed development of COVID-19 vaccines

Live with Dr. Jane Ruby: Trump's 2019 executive order enabled rushed development of COVID-19 vaccines – Brighteon.TV

By maryvillarealdw // 2022-05-06

Copy

In September 2019, President Donald Trump signed an executive order seeking to modernize the influenza vaccine manufacturing processes and develop vaccines that provide more effective and longer-lasting protection. It didn't turn out that way. Dr. Jane Ruby pointed out on the May 2 edition of "Live with Dr. Jane Ruby" on Brighteon.TV that the vaccine modernization executive order "opened a door of horrors" as it virtually eliminated the accountability of all agencies that were originally created to protect the public. In essence, Trump's executive order enabled the rushed development of Wuhan coronavirus (COVID-19) vaccines. Ruby said the majority of Americans don't really know about the executive order or understand what was in it. Most people thought it sounded good as it will improve the technology of vaccines and make them safer. However, that wasn't really the case. What it did was establish the Vaccine Task Force, bringing together multiple federal agencies like the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). By putting vaccine development in high gear, they ended up with dangerous vaccines featuring zero safety and efficacy. The terms safety and efficacy, according to Ruby, are not used in the pharmaceutical, drug development or medical world as far as vaccines are concerned. They are supposed to have a certain number of trials, but some of these trials were never done or had to be abandoned to rush the vaccines. Trump's executive order let that happen. (Related: Lawfare with Tom Renz: Gov. Abbott's executive order banning vaccine mandates came too late – Brighteon.TV.) Viral illnesses mutate quickly, to the point that it's just not medically or scientifically sound to use vaccines in addressing them. The FDA either allowed or insisted on the release of the vaccines, bypassing all of the safety processes and making the vaccines very dangerous. All the safety requirements, including human subjects review boards, were abandoned.

Pandemic simulation organized two months before first case of COVID-19 emerged

The executive order was signed about one month before the Event 201 pandemic simulation. It was an exercise organized in October 2019 to simulate what might happen if there's a severe pandemic. Interestingly, the first confirmed case of COVID-19 emerged just two months later in Wuhan, China. Trump's executive order initially called the situation an "influenza pandemic," but unlike seasonal influenza it has the potential to spread rapidly around the globe, with higher numbers of people causing high rates of illnesses and deaths. It also went on to say that vaccination is the most effective defense against influenza. But because these viruses mutate so quickly, the original strains are long gone by the time vaccines come out – which is why they are only around 25 to 30 percent effective. The executive order referred to the method of egg-based vaccine production as outdated and called upon the expansion of alternative methods that would allow for quicker responses to the emerging influenza viruses. "It is the policy of the United States to modernize the domestic influenza vaccine enterprise to be highly responsive, flexible, scalable, and more effective at preventing the spread of influenza viruses," the order stated. The Vaccine Task Force, which was established under the order, should compile a report, including a five-year-plan to promote new vaccine manufacturing technology and accelerate the development of a universal flu vaccine. Ruby pointed out that despite the report being part of the order, there had been no news about it in the media. Two months after Trump signed the order, someone in leadership was obligated to go before the House Energy Committee to explain the technical portion of the order. This person's testimony talked about how the National Institute of Allergy and Infectious Diseases is conducting and supporting research to develop state-of-the-art vaccine platform technologies. However, these technologies are not to be deployed immediately. The "money sentence," according to Ruby, is that these platform technologies "include DNA, messenger RNA, virus-like particles, vector-based and ready, self-assembling nanoparticle vaccines." Watch the full May 2 edition of "Live with Dr. Jane Ruby" to learn more about Trump's vaccine modernization executive order. Catch new episodes of the program every Monday at 7-8 p.m. on Brighteon.TV.

NATURAL NEWS

Pandemic simulation organized two months before first case of COVID-19 emerged

More related stories: